The Cell Culture Media industry size is expected to be worth US$ 3.3 billion in 2023 and US$ 6.4 billion by 2033. Cell Culture Media sales are expected to expand at a 7.0% CAGR during the projected period.
Biopharmaceutical development, manufacture, and research are all based on culture medium. Cell culture medium are used in biopharmaceutical research at all stages of the drug development process, from discovery to manufacture.
Get Sample PDF@ https://www.futuremarketinsights.com/reports/sample/rep-gb-14366
Because biologics are becoming more popular, the market for culture media has grown dramatically, as scientists require media to make their work practical. Furthermore, the market is developing as a result of rising demand for vaccinations against various diseases.
The global prevalence of chronic diseases is rising dramatically. The principal causes of a rise in chronic illness rates are lifestyle changes and an ageing population. As a result, the adoption of culture media is being driven by the demand for effective chronic disease therapy.
Infrastructure development, technical advancement, and modernization of the healthcare sector around the world, as well as an increase in diagnostic labs, will aid in the expansion of the market for cultured medium.
The market is expected to grow as a result of increased research efforts in areas like as cancer, stem cells, biopharmaceuticals, and others, as well as rising R&D spending.
However, it is expected that a shortage of qualified specialists with ethical and scientific concerns will limit market growth. On the other hand, the market for culture media is expected to grow rapidly due to untapped potential in developing countries and media innovation.
For any Queries Related to the Report, Ask an Analyst@ https://www.futuremarketinsights.com/ask-question/rep-gb-14366
Key Takeaways from Market Study
- In terms of CAGR rate, serum-free media grew at a substantial rate of 6.9%. SFM is an important technology that allows researchers to carry out specific applications or produce a certain cell type without the need of serum.
- During the projection period, the cancer research category is expected to grow at a significant CAGR of 7.5%. The expanding biologics research and development activities, as well as the growing requirement for vaccine production, are expected to drive the expansion of the cancer research segment.
- The United States market retains a solid position in the global market, with a revenue share of more than US$ 1.9 billion in 2023. The existence of a large number of enterprises is one of the primary reasons driving the market’s expansion. Because the pharmaceutical industry is more research-intensive, cultural media is in high demand.
- China is the most profitable region, rising at an astounding pace of 9.0% during the analysed period. Because of increased investments in the pharmaceutical and biopharmaceutical sectors, the China regional market is expected to grow rapidly throughout the forecast period.
Competitive Landscape:
To increase their market position, key players in this sector are using a variety of techniques, such as partnerships through mergers and acquisitions, geographic growth, and strategic collaborations. For instance, in July 2021, Sartorius purchased Xell AG, a leader in cell culture, through its subsidiary Sartorius Stedim Biotech. The business creates, manufactures, and sells feed additives and media for cell cultures, primarily for the production of viral vectors used in vaccine and gene therapy production.
Latest Developments:
- Captivate Bio introduced its line of cell culture tools in January 2021 to help in the fight against COVID-19 and other new diseases.
- Chemovator GmbH introduced its first product line, BIOFLOAT, in May 2020. This line consists of surface coatings for cell culture consumables.
For in-depth competitive analysis, Buy Now@ https://www.futuremarketinsights.com/checkout/14366
Key Segments
By Type:
- Serum-free Media
- CHO Media
- HEK 293 Media
- BHK Media
- VERO Cell Media
- Insect Cell Media
- Serum-free Stem Cell Media
- CAR T-cell Media
- Other Serum-free Media
- Classical Media & Salts
- Stem Cell Culture Media
- Specialty Media
- Chemically defined Media
- Other Cell Culture Media
By Application:
- Biopharmaceutical Production
- Monoclonal antibodies
- Vaccines production
- Other therapeutic proteins
- Diagnostics
- Drug Screening & Development
- Tissue Engineering & Regenerative Medicine
- Cell and gene therapy
- Other tissue engineering & regenerative medicine applications
- Other Application
By End User:
- Pharmaceutical & Biotechnology Companies
- Hospitals & Diagnostic Laboratories
- Research & Academic Institutes
- Others
About Future Market Insights, Inc.
Future Market Insights, Inc. (ESOMAR certified, Stevie Award – recipient market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.
Contact:
Future Market Insights, Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Browse All Reports: https://www.futuremarketinsights.com/reports
LinkedIn | Twitter | Blogs